Biodesix, Inc. (BDSX)
Nasdaq: BDSX · Services-Medical Laboratories · Louisville, CO · filing with the SEC since 2008
Who owns Biodesix, Inc.
As filed with the SECHolders of 5% or more
4
Schuler Jack W holds 24% of Common Stock, par value $0.001 per share, as its SCHEDULE 13D/A filed Jan 27, 2026 says.
Directors and officers
12
report now, of 15 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Schuler Jack W
SCHEDULE 13D/A · filed Jan 27, 2026 · Common Stock, par value $0.001 per share · 27% in Sep 23, 2025
Orin Hirschman
SCHEDULE 13G · filed Apr 28, 2026 · Common Stock, par value $0.001 per share
Telemark Asset Management, LLC
SCHEDULE 13G · filed Jan 26, 2026 · Common stock, par value $0.001 per share · 4.1% in Jan 23, 2026
Soleus Capital Master Fund, L.P.
SCHEDULE 13G · filed Jun 18, 2026 · Common Stock, par value $0.001 per share · 4.1% in May 8, 2026
Perceptive Advisors LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.001 par value per share · reported falling below 5%, from 5.1% in May 15, 2025
What BDSX reports owning in othersstakes of 5% or more, and other ties
Biodesix, Inc. reports no stake in another company in the record.
Insider tradesForm 4
15sales
7purchases
0sales on a scheduled plan
5people selling
$100,000sold, in dollars
$4.1Mbought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 15 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Hutton Scott | President & CEO | 3 | $100,000 | 0 | 0 | $0 |
| Schuler Jack W | director | 0 | $0 | 0 | 7 | $4.1M |
| Cowie Robin Harper | CFO, Sec'y & Treasurer | 3 | $0 | 0 | 0 | $0 |
| O'Kane Kieran | Chief Commercial Officer | 3 | $0 | 0 | 0 | $0 |
| Pestano Gary Anthony | Chief Development Officer | 3 | $0 | 0 | 0 | $0 |
| Vazquez Chris | Chief Accounting Officer | 3 | $0 | 0 | 0 | $0 |